SELLAS Life Sciences Group, Inc. Litigation Settlement, Amount (Deprecated 2017-01-31)
SELLAS Life Sciences Group, Inc. (SLS) reported Litigation Settlement, Amount (Deprecated 2017-01-31) of $0 for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmount · last filed 2017-11-09
- SELLAS Life Sciences Group, Inc. litigation settlement, amount (deprecated 2017-01-31) for the quarter ending 2017-09-30 was $0.00.
- SELLAS Life Sciences Group, Inc. litigation settlement, amount (deprecated 2017-01-31) for the quarter ending 2017-06-30 was -$1.30M.
- SELLAS Life Sciences Group, Inc. litigation settlement, amount (deprecated 2017-01-31) for the quarter ending 2016-12-31 was $29.55M.
- SELLAS Life Sciences Group, Inc. litigation settlement, amount (deprecated 2017-01-31) for the quarter ending 2016-09-30 was $0.00.
- SELLAS Life Sciences Group, Inc. litigation settlement, amount (deprecated 2017-01-31) for fiscal 2016 was $27.75M.
| Period end | Litigation Settlement, Amount (Deprecated 2017-01-31) | Litigation Settlement, Amount (Deprecated 2017-01-31) 3 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 6 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 9 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | -$1.30M derived: sum of 2 quarters · filed 2017-11-09 | -$1.30M 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | -$1.30M 10-Q · filed 2017-08-14 | -$1.30M 10-Q · filed 2017-08-14 | |||
| 2016-12-31 | $29.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $29.55M derived: sum of 2 quarters · filed 2017-11-09 | $27.75M derived: sum of 3 quarters · filed 2017-11-09 | $27.75M 10-K · filed 2017-03-15 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | -$1.80M derived: sum of 2 quarters · filed 2017-11-09 | -$1.80M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$1.80M 10-Q · filed 2017-08-14 | -$1.80M 10-Q · filed 2017-08-14 | $26.80M 10-Q · filed 2016-11-09 | ||
| 2016-03-31 | $25.00M 10-Q · filed 2016-05-10 | ||||
| 2015-12-03 | $25.00M 10-K/A · filed 2016-04-15 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |